Literature DB >> 22342744

Genetic diversity, population structure and drug resistance of Mycobacterium tuberculosis in Peru.

C A Taype1, J C Agapito, R A Accinelli, J R Espinoza, S Godreuil, S J Goodman, A L Bañuls, M A Shaw.   

Abstract

This paper presents the first evaluation of the molecular epidemiology of Mycobacterium tuberculosis in Peru. We characterised 323 isolates using spoligotyping and mycobacterial interspersed repetitive units variable number tandem repeats (MIRU-VNTR) typing. We aimed to determine the levels of genetic diversity and genetic differentiation among and within Peruvian isolates and the epidemiological factors which may be driving patterns of population structure and evolution of M. tuberculosis in Peru. Our results compared to the fourth international spoligotyping database (SpolDB4) and MIRU-VNTRplus, show that the main M. tuberculosis families present are Latin American-Mediterranean, Haarlem, T, and Beijing. Bayesian clustering recovered 15 groups in the Peruvian M. tuberculosis isolates, among which two were composed mainly of orphans, implying the presence of native "Peruvian" strains not previously reported. Variable levels of association with drug resistance were observed, with Beijing genotypes not showing any association with multidrug resistance, while in other groups MIRU-VNTR loci 2, 23, 31, and 40 were found to be associated with the multidrug-resistant tuberculosis (MDR-TB) phenotype, suggesting that a linkage disequibrium between these MIRU and drug resistance loci may be present. Genetic differentiation was present among drug resistant and sensitive strains. Ethambutol appeared to be the main driver of differentiation, suggesting that strong selection pressure could have been exerted by drug treatment in Peru over recent years.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342744     DOI: 10.1016/j.meegid.2012.02.002

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  19 in total

1.  Predominant Mycobacterium tuberculosis Families and High Rates of Recent Transmission among New Cases Are Not Associated with Primary Multidrug Resistance in Lima, Peru.

Authors:  Francesca Barletta; Larissa Otero; Bouke C de Jong; Tomotada Iwamoto; Kentaro Arikawa; Patrick Van der Stuyft; Stefan Niemann; Matthias Merker; Cécile Uwizeye; Carlos Seas; Leen Rigouts
Journal:  J Clin Microbiol       Date:  2015-03-25       Impact factor: 5.948

2.  Multidrug-resistant tuberculosis in panama is driven by clonal expansion of a multidrug-resistant Mycobacterium tuberculosis strain related to the KZN extensively drug-resistant M. tuberculosis strain from South Africa.

Authors:  Fedora Lanzas; Petros C Karakousis; James C Sacchettini; Thomas R Ioerger
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

Review 3.  Circulation of M. tuberculosis Beijing genotype in Latin America and the Caribbean.

Authors:  M I Cerezo-Cortés; J G Rodríguez-Castillo; R Hernández-Pando; M I Murcia
Journal:  Pathog Glob Health       Date:  2020-01-05       Impact factor: 2.894

4.  Genetic diversity of Mycobacterium tuberculosis in Peru and exploration of phylogenetic associations with drug resistance.

Authors:  Patricia Sheen; David Couvin; Louis Grandjean; Mirko Zimic; Maria Dominguez; Giannina Luna; Robert H Gilman; Nalin Rastogi; David A J Moore
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

5.  A first insight on the population structure of Mycobacterium tuberculosis complex as studied by spoligotyping and MIRU-VNTRs in Santiago, Chile.

Authors:  María Elvira Balcells; Patricia García; Paulina Meza; Carlos Peña; Marcela Cifuentes; David Couvin; Nalin Rastogi
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

6.  The Association between Mycobacterium Tuberculosis Genotype and Drug Resistance in Peru.

Authors:  Louis Grandjean; Tomotada Iwamoto; Anna Lithgow; Robert H Gilman; Kentaro Arikawa; Noriko Nakanishi; Laura Martin; Edith Castillo; Valentina Alarcon; Jorge Coronel; Walter Solano; Minoo Aminian; Claudia Guezala; Nalin Rastogi; David Couvin; Patricia Sheen; Mirko Zimic; David A J Moore
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

7.  Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis.

Authors:  Christopher B Ford; Rupal R Shah; Midori Kato Maeda; Sebastien Gagneux; Megan B Murray; Ted Cohen; James C Johnston; Jennifer Gardy; Marc Lipsitch; Sarah M Fortune
Journal:  Nat Genet       Date:  2013-06-09       Impact factor: 38.330

8.  Genetic diversity and transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru.

Authors:  Tomotada Iwamoto; Louis Grandjean; Kentaro Arikawa; Noriko Nakanishi; Luz Caviedes; Jorge Coronel; Patricia Sheen; Takayuki Wada; Carmen A Taype; Marie-Anne Shaw; David A J Moore; Robert H Gilman
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

9.  Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-Eastern part of Lima, Peru.

Authors:  Francesca Barletta; Larissa Otero; Jimena Collantes; Belisa Asto; Bouke C de Jong; Carlos Seas; Leen Rigouts
Journal:  BMC Infect Dis       Date:  2013-08-28       Impact factor: 3.090

10.  Functional Analysis Using Whole-Genome Sequencing of a Drug-Sensitive Mycobacterium tuberculosis Strain from Peru.

Authors:  D Tarazona; V Borda; M Galarza; J C Agapito; H Guio
Journal:  Genome Announc       Date:  2014-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.